Dennis Henriksen

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M

Ventac Partners thesis

Rancho Santa Fe Bio RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. The company is developing Ataciguat: a small molecule drug developed to… Read More

Sector and stage focus

  • Seed: Pharmaceuticals, BioTech
  • Series A: Pharmaceuticals, BioTech

Is Dennis Henriksen a fit for your round?

Upload your pitch deck and see whether Dennis Henriksen appears in your top 20 matches.

Find investors for your deck